364 related articles for article (PubMed ID: 18616726)
1. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
Mastrolonardo M
Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
[TBL] [Abstract][Full Text] [Related]
2. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
3. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
Nelson C; Rigel D; Smith S; Swanson N; Wolf J
J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
[TBL] [Abstract][Full Text] [Related]
4. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
Van der Geer S; Krekels GA
J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
[TBL] [Abstract][Full Text] [Related]
5. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
Berlin JM; Rigel DS
J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
[TBL] [Abstract][Full Text] [Related]
6. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
[TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
[TBL] [Abstract][Full Text] [Related]
8. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
Vlachou C; Kanelleas AI; Martin-Clavijo A; Berth-Jones J
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1343-5. PubMed ID: 18554227
[TBL] [Abstract][Full Text] [Related]
9. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
10. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
Martin GM; Stockfleth E
J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
[TBL] [Abstract][Full Text] [Related]
11. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Rivers JK; McLean DI
Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
[TBL] [Abstract][Full Text] [Related]
12. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
[TBL] [Abstract][Full Text] [Related]
13. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
Çayirli M; Köse O; Demiriz M
Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
[TBL] [Abstract][Full Text] [Related]
14. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
Smith SR; Morhenn VB; Piacquadio DJ
J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
[TBL] [Abstract][Full Text] [Related]
15. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
[TBL] [Abstract][Full Text] [Related]
16. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
Rivers JK
Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
[TBL] [Abstract][Full Text] [Related]
17. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
Patel MJ; Stockfleth E
Br J Dermatol; 2007 May; 156 Suppl 3():53-6. PubMed ID: 17488408
[TBL] [Abstract][Full Text] [Related]
18. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
[TBL] [Abstract][Full Text] [Related]
19. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
[TBL] [Abstract][Full Text] [Related]
20. Topical diclofenac gel for the management of periocular actinic keratosis.
Batra R; Sundararajan S; Sandramouli S
Ophthalmic Plast Reconstr Surg; 2012; 28(1):1-3. PubMed ID: 21785377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
